Search Results
UKALL14: implementing genetics in ALL research
UKALL14: rituximab dose & reduced intensity transplant in B-ALL & nelarabine consolidation in T-ALL
Combining MRD with genetic knowledge in ALL
New subtypes of acute lymphoblastic leukemia (ALL) – potential treatment identification by genomics
Building genetic assessments into how we determine prognosis of ALL
UKALL14 Asparaginase - Adele Fielding, MB, BS, PhD
Prognostic impact of chromosomal abnormalities and copy number alterations in B-cell precursor A...
Five decades of UKALL -Lessons learnt and future directions.
Reduced-intensity conditioning regimens for adults with ALL: UKALL14 & ALL-RIC
Advances in risk-stratification in pediatric ALL
Treatment of ALL, with a Special Focus on the Role of Asparaginase and Conventional Chemotherapy
Prof Anthony Moorman, Newcastle University, HARMONY Partner
